APA

Jundt F., Raetzel N., Müller C., Calkhoven C. F., Kley K., Mathas S., Lietz A., Leutz A. & Dörken B. (20050929). A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas. : Blood.

Chicago

Jundt Franziska, Raetzel Nina, Müller Christine, Calkhoven Cornelis F, Kley Katharina, Mathas Stephan, Lietz Andreas, Leutz Achim and Dörken Bernd. 20050929. A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas. : Blood.

Harvard

Jundt F., Raetzel N., Müller C., Calkhoven C. F., Kley K., Mathas S., Lietz A., Leutz A. and Dörken B. (20050929). A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas. : Blood.

MLA

Jundt Franziska, Raetzel Nina, Müller Christine, Calkhoven Cornelis F, Kley Katharina, Mathas Stephan, Lietz Andreas, Leutz Achim and Dörken Bernd. A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein {beta} and NF-{kappa}B activity in Hodgkin and anaplastic large cell lymphomas. : Blood. 20050929.